Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance

Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance and is associated with a high rate of mortality. Individuals with chronic viral hepatitis and other forms of liver disease are at risk for developing HCC. The stage of cancer dictates the therapeutic choice, making early detection a primary objective. Many observational studies have reported that HCC is diagnosed at an earlier stage in patients who received surveillance. The guidelines of the American Association for the Study of Liver Diseases suggest that surveillance should be performed using ultrasonography at an interval of every 6–12 months. This interval is based upon mainly observational data and the expected growth rates of HCC. Patients with abnormal screening tests require additional investigation using computed tomography scanning, magnetic resonance imaging, or liver biopsy. Although the optimal methods of screening and the cost-effectiveness of surveillance for HCC remain to be established, systematic screening still offers the best hope for early diagnosis, treatment eligibility, and improved survival. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Digestive Diseases Karger

Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance

Cabibbo, Giuseppe; Craxì, Antonio
Digestive Diseases , Volume 27 (2): 6 – Jun 1, 2009
Download PDF
6 pages

Loading next page...
 
/lp/karger/hepatocellular-cancer-optimal-strategies-for-screening-and-AamYP8IZp8

References (45)

Publisher
Karger
Copyright
© 2009 S. Karger AG, Basel
ISSN
0257-2753
eISSN
1421-9875
DOI
10.1159/000218346
Publisher site
See Article on Publisher Site

Abstract

Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance and is associated with a high rate of mortality. Individuals with chronic viral hepatitis and other forms of liver disease are at risk for developing HCC. The stage of cancer dictates the therapeutic choice, making early detection a primary objective. Many observational studies have reported that HCC is diagnosed at an earlier stage in patients who received surveillance. The guidelines of the American Association for the Study of Liver Diseases suggest that surveillance should be performed using ultrasonography at an interval of every 6–12 months. This interval is based upon mainly observational data and the expected growth rates of HCC. Patients with abnormal screening tests require additional investigation using computed tomography scanning, magnetic resonance imaging, or liver biopsy. Although the optimal methods of screening and the cost-effectiveness of surveillance for HCC remain to be established, systematic screening still offers the best hope for early diagnosis, treatment eligibility, and improved survival.

Journal

Digestive Diseases – Karger

Published: Jun 1, 2009

Keywords: Hepatocellular carcinoma; Risk factors; Screening; Surveillance

There are no references for this article.